Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Urinary Tract Infection

Free Subscription Articles published in Clin Infect Dis Retrieve available abstracts of 51 articles: HTML format

Single Articles

July 2026
1. SHEETS A, Dennison J, Han JH, Watts S, et al
   Subgroup Analysis of Pooled Phase 3 Efficacy Data from Two Randomized Trials of Gepotidacin Versus Nitrofurantoin in Uncomplicated Urinary Tract Infections (EAGLE-2 and EAGLE-3) including Participants with Uropathogens Not-Susceptible to Nitrofurantoi
   Clin Infect Dis. 2026 Jul 8:ciag408. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. GEERLINGS SE
   The balance between a new Antibiotic and Non-antibiotic Alternatives for the treatment and prevention of uncomplicated Urinary Tract Infections.
   Clin Infect Dis. 2026 Jul 7:ciag409. doi: 10.1093.
   PubMed    
   
   
   June 2026
3. SEO JW, Kim DY, Yoon Y, Lyu YS, et al
   Fosfomycin as Oral Transition Therapy Versus Continued Intravenous beta-Lactams for Complicated Urinary Tract Infections Caused by Extended-Spectrum beta-Lactamase-Producing Enterobacterales: A Multicenter, Open-Label, Randomized Controlled Trial.
   Clin Infect Dis. 2026 Jun 18:ciag345. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2026
4. FAFI I, Levy C, Birgy A, Bechet S, et al
   Impact of Respiratory Syncytial Virus Immunization on the Rate of Pediatric Acute Otitis Media: A Time-series Analysis.
   Clin Infect Dis. 2026;82:658-664.
   PubMed     Abstract available
   
   
   February 2026
5. CANTON R, Lim AN, Cortes V, Diaz-Reganon J, et al
   Uncomplicated Urinary Tract Infections: From an Invisible Impact to a Visible Change in Complex Care.
   Clin Infect Dis. 2026 Feb 25:ciaf705. doi: 10.1093.
   PubMed     Abstract available
   
   
   January 2026
6. SHEETS AJ, Dennison J, Pogue JM, Kaye KS, et al
   Early symptom response in patients with uncomplicated urinary tract infection treated with gepotidacin or nitrofurantoin: pooled analysis from two pivotal Phase 3 studies.
   Clin Infect Dis. 2026 Jan 6:ciaf722. doi: 10.1093.
   PubMed     Abstract available
   
   
   December 2025
7. TRAUTNER BW, Cortes-Penfield NW, Gupta K, Hirsch EB, et al
   Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Introduction and Methods.
   Clin Infect Dis. 2025 Dec 30:ciaf459. doi: 10.1093.
   PubMed    
   
   
   
8. TANDE AJ, Stevens RW, Ilges D, Lahr BD, et al
   Cumulative Antibiotic Exposure Is Associated With Ceftriaxone Resistance Among Patients With Urinary Source Gram-negative Bloodstream Infection: A Retrospective Cohort Study.
   Clin Infect Dis. 2025;81:871-878.
   PubMed     Abstract available
   
   
   
9. TRAUTNER BW, Cortes-Penfield NW, Gupta K, Hirsch EB, et al
   Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Duration of Antibiotics for Complicated UTI.
   Clin Infect Dis. 2025 Dec 20:ciaf462. doi: 10.1093.
   PubMed    
   
   
   
10. TRAUTNER BW, Cortes-Penfield NW, Gupta K, Hirsch EB, et al
    Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Patient Perspectives.
    Clin Infect Dis. 2025 Dec 19:ciaf463. doi: 10.1093.
    PubMed    
    
    
    
11. TRAUTNER BW, Cortes-Penfield NW, Gupta K, Hirsch EB, et al
    Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Selection of Antibiotic Therapy for Complicated UTI.
    Clin Infect Dis. 2025 Dec 19:ciaf460. doi: 10.1093.
    PubMed    
    
    
    
12. TRAUTNER BW, Cortes-Penfield NW, Gupta K, Hirsch EB, et al
    Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Timing of Intravenous to Oral Antibiotics Transition for Complicated UTI.
    Clin Infect Dis. 2025 Dec 19:ciaf461. doi: 10.1093.
    PubMed    
    
    
    September 2025
13. ALSHANQEETI S, Coffey K, Mcdermott K, de Guzman A, et al
    Comparing generative artificial intelligence vs. experts for detection of catheter-associated urinary tract infection (CAUTI).
    Clin Infect Dis. 2025 Sep 9:ciaf486. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2025
14. RUFFIN F, Sutton KN, Miller J, Lane H, et al
    A Qualitative Secondary Analysis of Patient Health-Related Quality of Life in Bloodstream Infections by Source: Intra-abdominal, Urinary Tract, and Acute Bacterial Skin and Skin Structure Infection.
    Clin Infect Dis. 2025;81.
    PubMed     Abstract available
    
    
    
15. MINTER DJ, Wang TW, Rader A, Barton KD, et al
    A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Complicated Urinary Tract Infections.
    Clin Infect Dis. 2025;81.
    PubMed     Abstract available
    
    
    July 2025
16. CLAEYS KC, Brown CH, Pineles L, Evans CT, et al
    Implementation of Diagnostic Stewardship to Improve Urinary Tract Infection Antibiotic Use Across Three Medical Centers.
    Clin Infect Dis. 2025 Jul 26:ciaf411. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
17. LODISE TP, Das AF, Frimodt-Moller N, Gupta K, et al
    Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infection: New Efficacy Analysis.
    Clin Infect Dis. 2025 Jun 26:ciaf280. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. LARACY JC, Chan JL, Kodama R, Yan J, et al
    Improving Urinary Tract Infection Diagnostics in Oncology: Reliability of Reflex Urine Culture in Immunosuppressed Neutropenic and Non-neutropenic Cancer Patients.
    Clin Infect Dis. 2025;80:969-974.
    PubMed     Abstract available
    
    
    
19. RAMIREZ-OLIVENCIA G, Fernandez Tomas M
    Considerations about patients with Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors treatment in recurrent urinary tract infections.
    Clin Infect Dis. 2025 Jun 3:ciaf287. doi: 10.1093.
    PubMed    
    
    
    April 2025
20. JONES KM, Greene MT, Meddings J, Mantey J, et al
    Impact of a Collaboration-Focused Intervention to Prevent Healthcare-Associated Infections Before and During the Coronavirus Disease 2019 Pandemic.
    Clin Infect Dis. 2025 Apr 29:ciaf122. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. KAYE KS, Santerre Henriksen A
    Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infections: The Full Picture Combines Extensive Clinical Experience and Emerging Data.
    Clin Infect Dis. 2025 Apr 11:ciaf183. doi: 10.1093.
    PubMed    
    
    
    
22. SFEIR MM
    Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infections: Beyond Safety and Tolerability, More Clinical and Diagnostic Questions Remain Unanswered.
    Clin Infect Dis. 2025 Apr 11:ciaf182. doi: 10.1093.
    PubMed    
    
    
    March 2025
23. ADVANI SD, Thaden JT, Perez R, Stair SL, et al
    State-of-the-Art Review: Recurrent Uncomplicated Urinary Tract Infections in Women.
    Clin Infect Dis. 2025;80:e31-e42.
    PubMed     Abstract available
    
    
    
24. ADVANI SD, Thaden JT, Perez R, Stair SL, et al
    Executive Summary: State-of-the-Art Review: Recurrent Uncomplicated Urinary Tract Infections in Women.
    Clin Infect Dis. 2025;80:491-493.
    PubMed    
    
    
    February 2025
25. KAYE KS, Santerre Henriksen A, Sommer M, Frimodt-Moller N, et al
    Safety and Tolerability of Pivmecillinam During More Than Four Decades of Clinical Experience: A Systematic Review.
    Clin Infect Dis. 2025;80:280-299.
    PubMed     Abstract available
    
    
    August 2024
26. STAUB M, Bennett J, Davis KW, Jansen JW, et al
    Population-Specific Urinalysis Parameters are Necessary to Improve Diagnostic Value for Urinary Tract Infection.
    Clin Infect Dis. 2024 Aug 19:ciae424. doi: 10.1093.
    PubMed    
    
    
    June 2024
27. WHITE AT, Vaughn VM, Petty LA, Gandhi TN, et al
    Development of Patient Safety Measures to Identify Inappropriate Diagnosis of Common Infections.
    Clin Infect Dis. 2024;78:1403-1411.
    PubMed     Abstract available
    
    
    April 2024
28. ADVANI SD, North R, Turner NA, Ahmadi S, et al
    Performance of Urinalysis Parameters in Predicting Urinary Tract Infection: Does One Size Fit all?
    Clin Infect Dis. 2024 Apr 26:ciae230. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. SHIELDS RK, Cheng WY, Kponee-Shovein K, Indacochea D, et al
    Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in E. coli-Causing Uncomplicated Urinary Tract Infection.
    Clin Infect Dis. 2024 Apr 4:ciae171. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2023
30. GUPTA V, Mastromarino P, Garg R
    Effectiveness of prophylactic oral and/or vaginal probiotic supplementation in the prevention of recurrent urinary tract infections: A randomized, double-blind, placebo-controlled trial.
    Clin Infect Dis. 2023 Dec 12:ciad766. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2023
31. 
    Correction to: Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial.
    Clin Infect Dis. 2023 Aug 17:ciad216. doi: 10.1093.
    PubMed    
    
    
    June 2023
32. BILSEN MP, Aantjes MJ, van Andel E, Stalenhoef JE, et al
    Current Pyuria Cutoffs Promote Inappropriate Urinary Tract Infection Diagnosis in Older Women.
    Clin Infect Dis. 2023;76:2070-2076.
    PubMed     Abstract available
    
    
    May 2023
33. GALLAGHER JC
    Taking on the Fundamental Questions in Infectious Diseases Two-at-a-Time.
    Clin Infect Dis. 2023;76:1613-1614.
    PubMed    
    
    
    April 2023
34. BULLOCH MN
    Optimal duration of therapy for inpatient complicated urinary tract infections remains undefined.
    Clin Infect Dis. 2023 Apr 6:ciad208. doi: 10.1093.
    PubMed    
    
    
    March 2023
35. DUNNE MW, Aronin SI, Das AF, Gupta J, et al
    Applying DOOR endpoint to randomized trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections.
    Clin Infect Dis. 2023 Mar 23:ciad149. doi: 10.1093.
    PubMed    
    
    
    February 2023
36. LAFAURIE M, Chevret S, Fontaine JP, Mongiat-Artus P, et al
    Antimicrobial for 7 or 14 days for febrile urinary tract infection in men: a multicenter noninferiority double blind placebo-controlled, randomized clinical trial.
    Clin Infect Dis. 2023 Feb 14:ciad070. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2023
37. MCATEER J, Lee JH, Cosgrove SE, Dzintars K, et al
    Defining the Optimal Duration of Therapy for Hospitalized Patients with Complicated Urinary Tract Infections and Associated Bacteremia.
    Clin Infect Dis. 2023 Jan 12:ciad009. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. KADRY N, Natarajan M, Bein E, Kim P, et al
    Discordant Clinical and Microbiological Outcomes are Associated with Late Clinical Relapse in Clinical Trials for Complicated Urinary Tract Infections (cUTI).
    Clin Infect Dis. 2023 Jan 10:ciad010. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2022
39. KARAKONSTANTIS S, Mpiliari E
    Fosfomycin oral step down for E. coli febrile urinary tract infections. Does the minimum inhibitory concentration (MIC) matter?
    Clin Infect Dis. 2022 Oct 20. pii: 6763736. doi: 10.1093.
    PubMed    
    
    
    September 2022
40. VAUGHN VM, Ratz D, Greene MT, Flanders SA, et al
    Antibiotic Stewardship Strategies and Their Association With Antibiotic Overuse After Hospital Discharge: An Analysis of the Reducing Overuse of Antibiotics at Discharge (Road) Home Framework.
    Clin Infect Dis. 2022;75:1063-1072.
    PubMed     Abstract available
    
    
    
41. RODRIGUEZ-BANO J, Gutierrez-Gutierrez B
    Opening a DOOR for pivotal studies: an example for complicated urinary tract infections.
    Clin Infect Dis. 2022 Sep 19. pii: 6705477. doi: 10.1093.
    PubMed    
    
    
    
42. DUNNE MW, Aronin SI, Das AF, Akinapelli K, et al
    Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3 Randomized Trial.
    Clin Infect Dis. 2022 Sep 7. pii: 6693482. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. DUNNE MW, Aronin SI, Das AF, Akinapelli K, et al
    Sulopenem For The Treatment of Complicated Urinary Tract Infection Including Pyelonephritis: A Phase 3 Randomized Trial.
    Clin Infect Dis. 2022 Sep 7. pii: 6693396. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2022
44. CLAEYS KC, Trautner BW, Leekha S, Coffey KC, et al
    Optimal Urine Culture Diagnostic Stewardship Practice-Results from an Expert Modified-Delphi Procedure.
    Clin Infect Dis. 2022;75:382-389.
    PubMed     Abstract available
    
    
    
45. HOWARD-ANDERSON J, Hamasaki T, Dai W, Collyar D, et al
    Improving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Complicated Urinary Tract Infection Clinical Trials.
    Clin Infect Dis. 2022 Aug 29. pii: 6678125. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. ADVANI SD, Sickbert-Bennett E, Moehring R, Cromer A, et al
    The Disproportionate Impact of COVID-19 Pandemic on Healthcare-Associated Infections in Community Hospitals: Need for Expanding the Infectious Disease Workforce.
    Clin Infect Dis. 2022 Aug 23. pii: 6673939. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2022
47. PATEL R, Polage CR, Dien Bard J, May L, et al
    Envisioning Future Urinary Tract Infection Diagnostics.
    Clin Infect Dis. 2022;74:1284-1292.
    PubMed     Abstract available
    
    
    December 2021
48. VAUGHN VM, Gandhi TN, Chopra V, Petty LA, et al
    Antibiotic Overuse After Hospital Discharge: A Multi-hospital Cohort Study.
    Clin Infect Dis. 2021;73:e4499-e4506.
    PubMed     Abstract available
    
    
    September 2021
49. OUATTARA M, Bassa FK, Diakite NR, Hattendorf J, et al
    Effectiveness of Four Different Interventions against Schistosoma haematobium in a Seasonal Transmission Setting of Cote d'Ivoire: A Cluster Randomized Trial.
    Clin Infect Dis. 2021 Sep 14. pii: 6369964. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2021
50. BAKER MA, Sands KE, Huang SS, Kleinman K, et al
    The Impact of COVID-19 on Healthcare-Associated Infections.
    Clin Infect Dis. 2021 Aug 9. pii: 6346721. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2021
51. KAYE KS, Gupta V, Mulgirigama A, Joshi AV, et al
    Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011-2019: Rising ESBL Strains and Impact on Patient Management.
    Clin Infect Dis. 2021 Jun 18. pii: 6304915. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Urinary Tract Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum